关于女性性功能障碍的新药治疗方法
Andrew How1, Christopher Jowdy1, Elli Novatcheva2
1University of Virginia School of Medicine.
Clinical obstetrics and gynecology
|January 23, 2025
概括
本综述研究了女性性功能障碍 (FSD) 的药理疗法,特别是低活性性欲障碍 (HSDD). 它指导临床医生使用FDA批准和正在研究的疗法来改善患者的结果和满意度.
科学领域:
- 药理学 药理学是指药理学的学科.
- 妇女健康 妇女健康
- 性医学性医学性医学性医学
背景情况:
- 女性性功能障碍 (FSD) 是影响生活质量的普遍问题.
- 低活性性欲障碍 (HSDD) 是一种常见的FSD亚型,需要有效的治疗策略.
研究的目的:
- 审查目前用于FSD的药理疗法,重点关注HSDD.
- 为已批准和正在研究的治疗方法的临床应用提供指导.
主要方法:
- 对FSD的药理干预措施的系统文献综述.
- 分析临床试验数据,安全概况和治疗指南.
主要成果:
- 对FDA批准的药物的评估:弗利班塞林和布雷梅拉诺提德.
- 评估包括Lorexys和丸激素组合在内的试验性疗法.
- 每种治疗方法的详细研究结果和安全性概况的摘要.
结论:
- 临床医生可以利用这篇评论来优化诊断,患者选择和FSD治疗的管理.
- 有效的期望设置,副作用管理和患者教育对于改善治疗成功和满意度至关重要.
更多相关视频
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
185
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
185
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
129
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
129
01:22Alzheimer's Disease: Treatment
160
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
160
01:25Antidepressant Drugs: Overview
353
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
353
01:28Drug Therapy
37
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
37
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
294
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
294